In Ovations Holdings, Inc. announced the implementation of the technology using sputum cytology for the early detection of lung cancer, a recognized laboratory procedure similar to the 'Pap' test.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% |
|
-.--% | -.--% |
2017 | In Ovations Holdings, Inc. Appoints Kenneth Hughes as Chief Science Officer | CI |
2017 | In Ovations Holdings, Inc. Announces Resignation of Rosendo Alvarez III as Officer and Director | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 5.56K | |
+18.10% | 72.21B | |
+5.35% | 17.12B | |
+15.11% | 14.08B | |
+14.91% | 12.91B | |
+11.73% | 9.8B | |
-14.43% | 7.29B | |
-10.54% | 5.59B | |
+1.74% | 5.19B | |
+2.17% | 5.12B |
- Stock Market
- Equities
- INOH Stock
- News In Ovations Holdings, Inc.
- In Ovations Holdings, Inc. Announces the Availability of the Early Detection of Lung Cancer Kit